HIV-exposed uninfected (HEU) children show impaired health outcomes during childhood. A high rate of mitochondrial DNA (mtDNA) instability was reported in the blood of HEU at birth. We aimed to explore the relationship between these health outcomes and mtDNA deletions over time in a case series of 24 HEU children. MtDNA instability was assessed by deep sequencing and analyzed by eKLIPse-v2 algorithm at three time points, namely birth, 1 year, and 6 years of age. Association between mtDNA deletion and health outcomes, including growth, clinical, and neurodevelopmental parameters, were explored using univariate statistical analyses and after stratification with relevant variables. HEU children were selected with an equal male:female ratio. An elevated number of mtDNA deletions and duplications events was observed at 7 days’ post-partum. Median heteroplasmy increased at one year of life and then returned to baseline by six years of age. The mtDNA instability was acquired and was not transmitted by the mother. No risk factors were significantly associated with mtDNA instability. In this small case series, we did not detect any association between any health outcome at 6 years and mtDNA instability measures. A significant effect modification of the association between the duration of maternal prophylaxis and child growth was observed after stratification with heteroplasmy rate. Genomic instability persists over time among HEU children but, despite its extension, stays subclinical at six years.
Background: Understanding drug use and behavior within the PWUD population is crucial to adapt harm reduction and prevention strategies, and provide improved addiction and medical treatment. However, in most countries such as France, the knowledge of drug use behaviors is likely biased as it originates from addiction centers which are attended by only an unknown proportion of PWUD. The objectives of this study were to describe drug use behavior in a population of active PWUD in the urban area of Montpellier, South of France. Methods: We implemented a community-based respondent-driven sampling survey (RDSS), a validated strategy to obtain a representative sample of a population, to recruit PWUD in the city. Adult individuals reporting frequent psychoactive drug use other than cannabis, with confirmation by urine test, were eligible. Beside HCV and HIV testing, trained peers interviewed participants on their drug consumption and behavior using standardized questionnaires. Fifteen seeds launched the RDSS. Results: During the 11 weeks of the RDSS, 554 actives PWUD were consecutively included. They were mostly men (78.8%), had a median age of 39 years, and only 25.6% had a stable living place. On average, participants consumed 4.7 (± 3.1) different drugs, and 42.6% smoked free-base cocaine. Unexpectedly, heroin and methamphetamine were consumed by 46.8% and 21.5% of participants, respectively. Among the 194 participants injecting drugs, 33% declared sharing their equipment. Conclusion: This RDSS highlighted a high consumption of heroin, crack and methamphetamine in this PWUD population. These unexpected results can be explained by low attendance to addiction centers, the source of drug use reports. Despite free care and risk reduction equipment in the city, sharing was very frequent among injectors, challenging the current program of harm reduction.
Background: Although people who inject drugs (PWID) are a high-risk group for tuberculosis (TB), current case-finding strategies fail to identify most TB cases. There is a need for an optimized community-based algorithm to improve TB detection in such disproportionately affected populations. Methods: Using respondent-driven sampling, we recruited PWID at community sites in Hai Phong, Vietnam, screening for classic TB symptoms, C-reactive protein blood measurement, portable on-site chest x-ray with CAD4TB software (Computer-Aided Detection for Tuberculosis version 7; Delft Imaging Systems BV), and Xpert MTB/RIF on sputum. Any participants suspected of TB by on-site physicians were referred to the infectious disease hospital for confirmatory testing, and external experts validated final diagnoses, which were then used as the TB gold standard. We aimed to identify the screening algorithm with the highest case detection at the lowest cost among different on-site testing combinations. Ingredients-based costing was used to evaluate the cost per test and cost per case detected for each algorithm. Results: Among the 1080 PWID enrolled, 47 (4.4%; 95% CI, 2.8%–6.4%) were diagnosed with TB disease. When compared with the current symptom-based TB screening strategy in Vietnam (Double X), systematic chest x-ray with CAD4TB, Xpert MTB/RIF for those with CAD4TB ≥50, and referral to care for those with either CAD4TB ≥70 or a positive Xpert test result doubled the sensitivity (82.9% vs 43.9%) and yield (3.2% vs 1.7%) while maintaining a reasonable cost per TB case detected (US $439 vs $309 for standard of care). Conclusions: We defined an acceptable and moderate cost algorithm that improves efficiency for community-based TB screening among PWID in Vietnam. To reflect real TB prevalence, we make the case that active case finding and systematic screening strategies should not limit testing to those with a positive symptom screen.
The factors influencing mother-to-child cell trafficking and persistence over children’s lives have yet to be established. The quantification of maternal microchimerism was previously reported through HLA-based approaches, which introduced bias regarding the tolerogenic environment. We aimed to identify cells of maternal origin irrespective of the HLA repertoire and to ascertain the determinants of microchimeric cells. This case–control study enrolled 40 male infants attending pediatric surgery from January 2022 to October 2022. Female cells were quantified in infants’ tonsil tissue by using cytogenetic fluorescent in situ hybridization (FISH) coupled with optimized automated microscopy. Out of the 40 infants, half (47.4%) had been breastfed for more than one month, a quarter for less a month, and 10 children (26.3%) were never breastfed. XX cells were observed in male tonsils in two-thirds of participants at a median density of 5 cells per 100,000 cells. In univariate analyses, child age was negatively associated with a high female cell density. In exploratory multivariate analyses, previous breastfeeding is a likely determinant of the persistence of these cells in the host, as well as the rank among siblings. Part of the benefit of breastmilk for child health may therefore be driven by breastfeeding-related microchimerism.
Infant postnatal prophylaxis (PNP) is universally recommended for all breastfed infants born from mothers living with HIV up to 6-weeks of age. Continuation of PNP was recommended for infants defined as at high-risk of HIV acquisition. We hypothesised that a single maternal viral load (mVL) at the end of the universal PNP period can accurately identify infants requiring extended prophylaxis. We assessed 1398 VL of breastfeeding mothers from Zambia and Burkina Faso at baseline (week 6-8), months 6 and 12 post-partum. Infants were defined at high-risk of HIV acquisition when mVL was ≥ 1000 cp/mL. Mothers with a VL between 40 and 1000 cp/mL or ≥ 1000 cp/mL at baseline were 6 [95CI 3.7-9.6] or 18 [95CI 12.6-25.7] times more likely to have a VL above 1000 cp/mL during breastfeeding than mothers with a VL below 40 cp/mL. A 40 cp/mL threshold for mVL showed a better performance to identify infants eligible for extended PNP in comparison with the standard threshold. A single mother VL at W6-8 enabled a sensitive identification of infants at risk of HIV acquisition throughout the breastfeeding period. This conclusion may pave the way for a simplified risk-stratified guideline for the initiation of extended infant PNP.